12 months exactly on 0.5 dut daily Finasteride/Dutasteride 7/22/2026
The user has been on dutasteride for 12 months and previously tried finasteride, but hair loss worsened, so they are now using both. They also use oral minoxidil, but results are still uncertain.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 20M, No Shedding on Oral Minoxidil 2.5mg After 16 Days – Should I Increase Dosage?
A 20-year-old experiencing diffuse thinning is using a regimen of oral minoxidil, dutasteride, finasteride, and ketoconazole to address hair loss. They are considering increasing the minoxidil dosage or adding topical treatments due to minimal shedding observed after 16 days.
community Dutasteride not working - is it the end?
The user tried topical minoxidil, topical and oral finasteride, and switched to dutasteride and oral minoxidil without success in stopping hair loss. Suggestions included continuing treatment longer, trying microneedling, and considering a hair transplant.
community Dutasteride 4 times a week not good as propecia every day with dutasteride every 5 days for me
Taking dutasteride daily with finasteride is more effective in reducing hair loss and itching than taking dutasteride four times a week. The combination reduces shedding and anxiety.
community Finasteride nuking 85%+ dht levels update
The user discovered their previous hair loss medication was counterfeit and switched to Propecia, which significantly lowered their DHT levels. They plan to continue using Propecia and add oral Minoxidil to their routine for better results.
community What are the Pros and Cons of taking Oral Minoxidil and Finasteride (Pills) Sublingually?
The user is considering taking 2.5 mg oral minoxidil and 1 mg oral finasteride sublingually to minimize side effects after a hair transplant. They seek advice on the pros and cons of this method, noting a lack of concrete information.
community No gains after 4 years of min and fin
User has seen no improvement after 4 years of using minoxidil and finasteride, and recently started dutasteride. Suggestions include adding oral minoxidil, microneedling, and considering a hair transplant.
Related Research
6 / 6 resultsresearch Treatment of Androgenetic Alopecia with Low Dose Oral Minoxidil Monotherapy Compared to Combination Therapy with Dutasteride or Finasteride
Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.
research Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
In this study, the authors reported that oral dutasteride at 0.5 mg/day showed a probable greater efficacy in treating male androgenetic alopecia compared to finasteride and minoxidil, but it may cause sexual dysfunction and neuropsychiatric side effects.
research Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
This study found that among various treatments for male androgenetic alopecia, dutasteride 0.5 mg/day was the most effective option overall. Additionally, among FDA-approved treatments, topical minoxidil 5% was the most effective topical therapy, and finasteride 1 mg/day was the most effective oral therapy.
research Evaluación de la eficacia y seguridad del tratamiento tópico y del tratamiento oral en la alopecia androgenética y hormonal
This study suggests that a combination of topical minoxidil with oral finasteride and dutasteride may promote new hair growth in androgenetic alopecia, with minor safety concerns reported.
research Evaluation of the efficacy and safety of topical and oral treatments on hormonal and androgenetic alopecia
This study suggests that a combination of topical minoxidil with oral finasteride or dutasteride promotes hair growth in treating androgenetic alopecia, with only minor safety concerns reported.
research Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
In this Delphi study, international experts established consensus-based guidelines for diagnosing and managing persistent chemotherapy-induced alopecia (pCIA), recommending prevention through scalp cooling and early use of minoxidil, while advising against bicalutamide and certain finasterides for breast cancer patients due to safety concerns.